Adam Manger

Adam Manger is a seasoned financial professional with extensive experience in the pharmaceutical and healthcare industries. Currently serving as Global Controller at BioCryst Pharmaceuticals, Inc. since June 2024, Adam previously held the position of Sr. Director - Accounting & Reporting at Centessa Pharmaceuticals from August 2021 to June 2024. Adam's career includes roles such as Director - Revenue / Alliance Finance at Teva Pharmaceuticals and Assistant Controller at both Eisai US and Axovant Sciences. Prior to these positions, Adam was an Assistant Controller at LifeCell, where a notable company acquisition by Allergan took place. Additional experience encompasses financial reporting and revenue recognition management at inVentiv Health Clinical and financial analysis positions at PepsiCo and PricewaterhouseCoopers. Adam earned a Bachelor of Science in Accounting from the Alfred Lerner College of Business & Economics at the University of Delaware.